Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report (Q34405065)

2 August 2017

Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report (English)

1 reference

2 August 2017

multiple drug resistance

1 reference

Michael Poles

14

0 references

Anita Shet

object named as

Anita Shet

4

0 references

Christos J Petropoulos

15

object named as

Christos Petropoulos

1 reference

2 August 2017

Martin Markowitz

1

1 reference

2 August 2017

Hiroshi Mohri

2

1 reference

2 August 2017

Saurabh Mehandru

3

1 reference

2 August 2017

Leslie Berry

5

1 reference

2 August 2017

Roopa Kalyanaraman

6

1 reference

2 August 2017

Alexandria Kim

7

1 reference

2 August 2017

Chris Chung

8

1 reference

2 August 2017

Patrick Jean-Pierre

9

1 reference

2 August 2017

Amir Horowitz

10

1 reference

2 August 2017

Melissa La Mar

11

1 reference

2 August 2017

Terri Wrin

12

1 reference

2 August 2017

Neil Parkin

13

1 reference

2 August 2017

Michael Mullen

16

1 reference

2 August 2017

Daniel Boden

17

1 reference

2 August 2017

David D Ho

18

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

2 August 2017

1 reference

2 August 2017

365

1 reference

2 August 2017

9464

1 reference

2 August 2017

1031-1038

1 reference

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

The prevalence of antiretroviral drug resistance in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

Antiretroviral-drug resistance among patients recently infected with HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

HIV-1 drug resistance in newly infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

Evolving patterns of HIV-1 resistance to antiretroviral agents in newly infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

Time trends in primary HIV-1 drug resistance among recently infected persons

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

Genotypic and phenotypic characterization of HIV-1 patients with primary infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

Infection with dual-tropic human immunodeficiency virus type 1 variants associated with rapid total T cell decline and disease progression in injection drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

Host determinants in HIV infection and disease. Part 2: genetic factors and implications for antiretroviral therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

Cross-resistance patterns among HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

The influence of HLA genotype on AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

Prolonged retention of drug resistance mutations and rapid disease progression in the absence of therapy after primary HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

Transmission of antiretroviral-drug-resistant HIV-1 variants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

Transmission of HIV-1 variants resistant to the three classes of antiretroviral agents: implications for HIV therapy in primary infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

Antiviral activity of tenofovir (PMPA) against nucleoside-resistant clinical HIV samples

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971139-9

7 January 2021

10.1016/S0140-6736(05)71139-9

Identifiers

DOI

1 reference

2 August 2017

1 reference